All News

Work is underway in the global phase 3 HARMONi study evaluating the combination of ivonescimab and chemotherapy in the treatment of patients with EGFR-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer.

Watch Dr. Jyoti Malhotra, from City of Hope, discuss advancements in advanced non-small cell lung cancer during the CURE® Educated Patient® Lung Cancer Summit.

I was diagnosed with cancer five years ago, and am extremely grateful for the people I met along the way.

The costs related to a cancer diagnosis go beyond treatment, reflecting the altered participation in the workforce for adolescents and young adults.

With each hike I complete, I feel empowered and reminded that breast cancer — and lingering lymphedema — cannot keep me down.

The drug combination of Lonsurf plus Avastin improved survival in patients with pretreated, metastatic, refractory colorectal cancer, according to recently published study findings.

Watch Dr. Erminia Massarelli, from City of Hope National Medical Center, discuss advancements in early-stage non-small cell disease during the CURE® Educated Patient® Lung Cancer Summit.

Among the extraordinary collection of givers are singular nurses who stand above the rest like a beacon guiding the profession toward its highest order. Anthony “Tony” Reynolds, RN, of ARH Cancer Center is one such nurse.

Watch Dr. Ravi Salgia, from City of Hope, discuss advancements in small cell lung cancer during the CURE® Educated Patient® Lung Cancer Summit.

After being diagnosed with a rare form of cancer — and seeing a clinician who did not know how to treat me — I learned the importance of asking questions to my providers and advocating for myself

Watch Dr. Ed Kim, Dr. Jyoti Malhotra and Terri Conneran answer questions about targeted therapy during the CURE® Educated Patient® Lung Cancer Summit.

For a young girl dying of cancer, whose mother had other children at home to take care of, Sobha Akkar, B.S.N., RN, OCN, became a motherly figure.

From music to poetry and dynamic storytelling, the first installment of CURE®’s Open Mic Showcase highlights the talents of patients and survivors of cancer.

The FDA approval of Epkinly also includes a subset of patients with indolent lymphoma-related DLBCL and those with high-grade B-cell lymphoma after two or more systemic therapies.

I hated the way that hormone drugs made me feel, so I spoke with my loved ones and oncology team and made the difficult decision to stop.

From a teen cancer survivor being gifted tickets to Taylor Swift’s ‘Eras’ tour to Michael Hendry backing out of the US Open due to a leukemia diagnosis, here’s what’s happening in the oncology space this week.

Watch Dr. Jyoti Malhotra, from City of Hope Orange County, discuss targeted therapy, during the CURE® Educated Patient® Lung Cancer Summit.

Tagrisso plus chemotherapy improved progression-free survival in patients with EGFR-mutated, locally advanced or metastatic non-small cell lung cancer, according to high-level results from a phase 3 trial.

Cryopreserved stem cells led to a higher rate of relapse in patients with blood cancer, though there was no difference in survival, research showed.

After being no evidence of disease for about a year and a half, I am now fearing that I’m not fearing enough.

Dr. Dawn Mussallem of the Mayo Clinic tells CURE®’s “Cancer Horizons” podcast about how surviving stage 4 non-Hodgkin’s lymphoma and being a heart transplant recipient helps her connect with her patients.

Watch an expert discuss biomarker testing during the CURE® Educated Patient® Lung Cancer Summit.

Breyanzi has reportedly shown promising effects for patients with relapsed or refractory follicular lymphoma and B-cell non-Hodgkin lymphoma.

Palliative care — which focuses on quality of life — did not significantly improve outcomes in patients when delivered at the point of oncology surgery, highlighting the need to better understand when the best time to provide the service would be.

I don't remember the first time I heard the word "germline," but I do remember when it became a major part of my life.

Patients with pancreatic cancer are treated with chemotherapy and surgery, depending on the stage, but more options are needed to treat a disease does not often respond to treatment.

Watch Dr. Thomas Waddington and Dr. Percy Lee answer questions about diagnostic and radiation advances during the CURE® Educated Patient® Lung Cancer Summit.

I knew that I was only one of Myra Escudero's, M.S.N., RN, many patients, but she made me feel as though I had her full attention and care.

Research found that patients diagnosed with cancer during pregnancy or postpartum tended to have slightly lower five-year survival rates than those diagnosed outside of that period.

After going through grueling cancer treatments, I thought I’d never be back to my old self again. But thankfully, that wasn’t the case.